As of 9:51 AM IST on February 13, pharma sector stocks were trading lower across exchanges, mirroring weakness in the broader market. The NIFTY 50 was down 0.95% at 25,560.85, while the S&P BSE SENSEX declined 0.93% to 82,895.08.
Most frontline pharmaceutical companies were in the red during early trade, with only a handful of stocks managing marginal gains.
Large-cap pharma stocks under pressure
Sun Pharma was trading 0.44% lower on the NSE at Rs. 1,707.40. Dr. Reddy’s Laboratories slipped 0.45% to Rs. 1,269.20, while Cipla was down 0.50% at Rs. 1,323.40.
Lupin declined 1.22% to Rs. 2,184.10 and Aurobindo Pharma fell 1.64% to Rs. 1,138.90.
Divi’s Laboratories was trading 0.79% lower at Rs. 6,136.00, while Zydus Lifesciences dropped 1.44% to Rs. 907.70.
Mid-cap and specialty pharma stocks see sharper cuts
Selling was more pronounced in several mid-cap counters. Cohance Lifesciences fell 7.80% on the NSE to Rs. 323.40, marking one of the steepest declines in the segment. Sai Life Sciences was down 4.15% at Rs. 891.40.
Jubilant Industries slipped 4.46% to Rs. 1,633.50, while SMS Pharmaceuticals declined 3.45% to Rs. 338.70. Alembic fell 3.36% to Rs. 95.27, and IPCA Laboratories dropped 2.19% to Rs. 1,440.70.
Other stocks trading lower included Gland Pharma, down 2.26%, Strides Pharma Science, down 1.51%, and Natco Pharma, which declined 1.57% on the NSE.
Select stocks buck the trend
Despite broad weakness, a few counters were trading in positive territory. Biocon gained 0.81% to Rs. 378.10 on the NSE. Bliss GVS Pharma rose 2.95% to Rs. 224.64, emerging as one of the top gainers within the sector.
Torrent Pharma was marginally higher by 0.68% at Rs. 4,104.80, while J.B. Chemicals & Pharmaceuticals advanced 0.36% to Rs. 1,916.90.
Broad trend
The overall trend at 9:51 AM IST indicates sector-wide pressure across large-cap, mid-cap, and specialty pharmaceutical stocks, with declines ranging from below 1% to over 7% in select counters.